Visceral disseminated varicella zoster virus infection following COVID-19 vaccination in an allogeneic stem cell transplant recipient.

Nishimoto, Mitsutaka; Sogabe, Nobuhiro; Hino, Masayuki

Nishimoto, Mitsutaka; Sogabe, Nobuhiro; Hino, Masayuki.

Nishimoto M; Department of Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Sogabe N; Department of Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Hino M; Department of Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Transpl Infect Dis ; 24(2): e13810, 2022 04.

Article in English | MEDLINE | ID: covidwho-1714321

Subject(s)

COVID-19; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Varicella Zoster Virus Infection; COVID-19 Vaccines/adverse effects; Hematopoietic Stem Cell Transplantation/adverse effects; Herpes Zoster/diagnosis; Herpesvirus 3, Human; Humans; Stem Cell Transplantation/adverse effects; Vaccination; Varicella Zoster Virus Infection/diagnosis; Varicella Zoster Virus Infection/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Varicella Zoster Virus Infection / COVID-19 / Herpes Zoster Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Transpl Infect Dis Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Tid.13810

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google